Position in ICLR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$8,454,639
+$2,947,755 QoQ
Shares Held
48,671
-2.2% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#99
of 422 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC holds $47,888,676 across 5 Diagnostics & Research names. ICLR ranks #3 (17.7% of the industry book) .
All Filings in ICLR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,454,639 | 48,671 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $5,506,884 | 49,764 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $9,271,171 | 50,879 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $9,028,250 | 51,590 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $7,308,571 | 50,248 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,488,872 | 42,796 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $8,132,763 | 38,781 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,820,199 | 16,777 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,230,560 | 16,686 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,409,466 | 16,102 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $4,419,288 | 15,612 | Shares | Sole | 2024-01-22 | |
| No filing history on record for this holder in this stock. | ||||||